Bionas and PRIMACYT to cooperate on cell-based assay for prediction of hepatotoxic effects of drugs and chemicals

22-Sep-2006

Bionas and PRIMACYT have entered into a cooperation aimed at the development of a cell-based assay using primary human hepatocytes for prediction of hepatotoxic effects in response to test compounds.

Primary human hepatocytes, provided by PRIMACYT, are cultivated directly on collagen-coated Bionas® metabolic chips. The chips are then placed into the Bionas analyzing system to evaluate the effect of test compounds. After a recovery period the hepatocytes can be re-used for further experiments.

Predicting liver toxicity is a major concern of the pharmaceutical industry and non-immortalized primary human hepatocytes can be used as biosensors for the analysis of drugs, food additives and chemicals.

Other news from the department business & finance

These products might interest you

Octet R2 / Octet R4 / Octet R8

Octet R2 / Octet R4 / Octet R8 by Sartorius

Full power on 2, 4 or 8 channels: Label-free and GxP-compliant analysis of molecular interactions

Innovative label-free real-time protein quantification, binding kinetics and rapid screenings

protein analyzers
Octet SF3

Octet SF3 by Sartorius

Surface Plasmon Resonance (SPR) using Single Dynamic Injections for Kinetics and Affinities

Curvature is Key - Adding a ‘Third Dimension’ to the Binding Curve

Octet RH16 and RH96

Octet RH16 and RH96 by Sartorius

Efficient protein analysis for process optimisation and manufacturing control in high-throughput

Label-free protein quantification and characterization of protein-protein interactions

protein analyzers
Loading...

More news from our other portals

So close that even
molecules turn red...